News stories about Balchem (NASDAQ:BCPC) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Balchem earned a daily sentiment score of 0.23 on Accern’s scale. Accern also assigned media coverage about the basic materials company an impact score of 46.3239802129508 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
Shares of BCPC stock traded up $0.46 on Thursday, reaching $81.75. 101,370 shares of the company’s stock traded hands, compared to its average volume of 111,262. The company has a current ratio of 1.84, a quick ratio of 1.28 and a debt-to-equity ratio of 0.31. Balchem has a 12-month low of $70.23 and a 12-month high of $88.47. The company has a market capitalization of $2,582.78, a price-to-earnings ratio of 29.30 and a beta of 1.05.
Balchem (NASDAQ:BCPC) last issued its earnings results on Tuesday, February 27th. The basic materials company reported $0.68 EPS for the quarter, beating analysts’ consensus estimates of $0.62 by $0.06. Balchem had a return on equity of 14.16% and a net margin of 15.14%. The firm had revenue of $159.26 million for the quarter.
WARNING: “Balchem (BCPC) Earning Somewhat Positive Media Coverage, Analysis Shows” was posted by BBNS and is the property of of BBNS. If you are accessing this article on another site, it was stolen and republished in violation of US & international copyright legislation. The correct version of this article can be viewed at https://baseballnewssource.com/2018/03/29/balchem-bcpc-receiving-somewhat-positive-media-coverage-analysis-finds/1971062.html.
Balchem Company Profile
Balchem Corporation is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization and industrial markets. The Company operates in four segments: Human Nutrition & Health, Animal Nutrition & Health, Specialty Products and Industrial Products.
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.